We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer RA Drug Could Be Delayed Past August by FDA Data Request
Pfizer RA Drug Could Be Delayed Past August by FDA Data Request
August 3, 2012
Pfizer’s rheumatoid arthritis (RA) candidate tofacitinib could see its review date pushed back thanks to an FDA request for an additional analysis.